shutterstock_314149679_canadastock

canadastock / Shutterstock.com

13 February 2020Big PharmaIQPC Exchange

Global IP Exchange Europe: IP leaders’ investment priorities revealed

In such a fast-moving and exciting area for many brands, the survey uncovered the specific challenges participants are facing in bringing their IP strategies to life.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Gilead scores win in fake HIV drug dispute

Dexcom suffers second patent revocation at hands of UPC

Sanofi signs global rights deal to develop rare cancer therapy

Novo Nordisk files fresh lawsuits to intercept Wegovy generics

AstraZeneca unit draws line under Samsung dispute

Does the UPC offer a fresh take on patent validity?

Regeneron targets almost 50 patents in suit against Sandoz

Litigation implications of the USPTO’s terminal disclaimer proposal